SBRI: Vaccine development for potential epidemic diseases

Funding for development of vaccines for epidemic diseases

The Department of Health and Social Care UK Vaccine Network is funding a Small Business Research Initiative (SBRI) competition to support further development of vaccine candidates, technologies and platforms against specified pathogens of epidemic potential including Disease X.

The UK Vaccine Network has identified a list of priority pathogens, though applications for work on other pathogens within the same family will be considered.

Your proposal can address any part of the development pathway in the UK or in relevant low and middle-income countries, including:

• pre-clinical and non-clinical development
• manufacturing process design
• phase 1 clinical trials

These must be within a 24-month time frame.

Your proposals must meet Official Development Assistance (ODA) requirements for funding.

This is stage 1 of a potential two-stage SBRI competition. The decision to proceed with an SBRI stage 2 competition will depend on the outcomes from stage 1 and assessment of a separate application into a subsequent SBRI stage 2 competition.

Only the successful applicants from the SBRI stage 1 will be invited to apply to take part in the stage 2.

Stage 1 projects can range in size up to total costs of £2 million.

Find out more about this SBRI competition.

First published 2 June 2023